Giordani Group
Giordani Group
Home
News & Outreach
Events
Media
Publications
People
Contact
Gemcitabine (GEM)-derived prodrugs
[OUTSIDE FRONT COVER] Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs
Carbon nano-onions (CNOs) are featured on this cover, illustrating a breakthrough in advanced materials for pancreatic cancer …
Michał Bartkowski
,
Valeria Bincoletto
,
Iris Chiara Salaroglio
,
Giacomo Ceccone
,
Raul Arenal
,
Sara Nervo
,
Barbara Rolando
,
Chiara Riganti
,
Silvia Arpicco
,
Silvia Giordani
Cite
DOI
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs
Nanotechnology’s potential in revolutionising cancer treatments is evident in targeted drug delivery systems (DDSs) engineered to …
Michał Bartkowski
,
Valeria Bincoletto
,
Iris Chiara Salaroglio
,
Giacomo Ceccone
,
Raul Arenal
,
Sara Nervo
,
Barbara Rolando
,
Chiara Riganti
,
Silvia Arpicco
,
Silvia Giordani
Cite
DOI
Cite
×
![[OUTSIDE FRONT COVER] Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs](/publication/bartkowski-outsidefrontcover-2024/featured_hu4533d8ada44e851cc23c77b2e7dedbee_588727_150x0_resize_q75_h2_lanczos.webp)
